MO064: Expression Studies on Magi2 in Different FSGS Models. (3rd May 2022)

• Record Type: Journal Article
• Authors: Hay, Eleonora; Siegerist, Florian; Schindler, Maximilian; Marie Bach, Sophia-; De Luca, Antonio; Chatziantoniou, Christos; Chadjichristos, Christos; Wiech, Thorsten; Endlich, Nicole
• Is Part Of: Nephrology dialysis transplantation. Volume 37(2022)Supplement 3
• Publication Date: 2022-05-03
• Subjects: Nephrology -- Periodicals; Hemodialysis -- Periodicals; Kidneys -- Transplantation -- Periodicals; Hemodialysis; Kidneys -- Transplantation; Nephrology; Periodicals; 616.61
• DOI: 10.1093/ndt/gfac063.016
• Languages: English
• ISSNs: 0931-0509

Abstract

Abstract: BACKGROUND AND AIMS: MAGI2 is a tight junction protein and member of the membrane-associated guanylate kinase (MAGUK) family. In the glomerulus, it is exclusively expressed in podocytes and interacts with the slit diaphragm protein nephrin. Recent studies and podocyte-specific MAGI2 knockout mice have demonstrated the essential role of this protein in the glomerulus. The aim of this work was to study the expression of MAGI2 in different focal segmental glomerulosclerosis (FSGS) mouse models, in the Glom Assay, in a FSGS-like zebrafish model, and in human biopsies of patients suffering from minimal change disease and FSGS. Additionally, using CRISPR/Cas9 knockout of magi2 and nephrin in zebrafish, we investigated the influence of both proteins on each other's localization. METHOD: We used nephrotoxic serum (NTS) as well as uninephrectomy DOCA/salt-induced hypertension as murine models. The podocyte-specific nitroreductase/metronidazole zebrafish model was used to induce FSGS-like disease in zebrafish upon partial podocyte-depletion. MAGI2 expression was evaluated in kidney biopsies of patients affected by minimal change disease (MCD), primary and secondary FSGS. Slides were imaged using confocal laser scanning and super-resolution 3D-structured illumination microscopy (3D-SIM). Filtration slit density (FSD) was measured on human biopsies by PEMP (p odocyte e xact m orphology m easurement p rocedure). MAGI2/nephrin ratio measurements were performed with a customized macro for the ImageJ-based platform FIJI. Magi2 expression was studied in the Glom Assay. To evaluate the interaction between magi2 and nephrin in the zebrafish model, the respective proteins were knocked-out using CRISPR/Cas9. The knockout was validated by RT–PCR and the expression of these two proteins in both lines was analyzed by immunofluorescence staining. Proteinuria was assessed using the excretion of eGFP-tagged vitamin D-binding protein from the vasculature and reuptake in proximal tubule cells. RESULTS: MAGI2 was expressed in a linear pattern along the filtration slit and colocalized with nephrin in all three species investigated (human, mouse and zebrafish) (3D-SIM in Fig. 1). MAGI2 was significantly downregulated in NTS-induced nephritis, as well as in uninephrectomized and DOCA/salt-treated mice. In the Glom Assay, Magi2 was significantly downregulated in dedifferentiated podocytes after 6 days in cell culture due to podocyte dedifferentiation. A reduction of MAGI2 was found in human biopsies of patients suffering from primary FSGS, but not in MCD and secondary FSGS, respectively. In addition, we found that magi2 was downregulated in zebrafish larvae using our FSGS-like zebrafish model. When we examined the effect of nephrin on magi2 expression and vice versa, we found that magi2 expression was unchanged in nephrin-KO larvae, whereas nephrin expression was significantly reduced in MAGI2a-KO larvae. CONCLUSION: Here, we have shown that the expression of MAGI2 in the glomerulus of different species such as zebrafish, mice and humans is associated with the expression of nephrin. By using knockout larvae, we showed that nephrin expression is dependent on Magi2 and not vice versa. Since the expression of Magi2 seems to be specifically regulated depending on the podocytopathy investigated, we propose a role for MAGI2 to distinguish between different glomerulopathies.